Palmitic Acid–Induced Long Noncoding RNA PARAIL Regulates Inflammation via Interaction With RNA-Binding Protein ELAVL1 in Monocytes and Macrophages

Inflammation 0303 health sciences Macrophages Palmitic Acid NF-kappa B RNA-Binding Proteins Atherosclerosis Monocytes ELAV-Like Protein 1 Mice 03 medical and health sciences Humans Animals RNA, Long Noncoding
DOI: 10.1161/atvbaha.122.318536 Publication Date: 2023-04-27T09:02:00Z
ABSTRACT
Background: Obesity and diabetes are associated with elevated free fatty acids like palmitic acid (PA), which promote chronic inflammation impaired resolution cardiometabolic disorders. Long noncoding RNAs (lncRNAs) implicated in inflammatory processes; however, their roles PA-regulated unclear. Methods: We performed RNA-sequencing analysis to identify coding genes novel lncRNAs CD14 + monocytes from healthy volunteers. investigated the regulation function of an uncharacterized PA-induced lncRNA PARAIL (PA- r egulated a nti- i nflammatory l ncRNA). examined its role by employing knockdown overexpression strategies human mouse macrophages. also used RNA pulldown coupled mass spectrometry interacting nuclear proteins mechanistic involvement functions Results: Treatment several phenotype. PA strongly induced expressed near RIPK2 . was cytokines infectious agents monocytes/macrophages regulated NF-κB (nuclear factor-kappa B). Time course studies showed during phase PA-treated antisense oligonucleotides upregulated key vice versa overexpression. found that interacts ELAVL1 (ELAV-like RNA-binding protein 1) via adenylate/uridylate–rich elements (AU-rich elements; AREs). inhibited anti-inflammatory Moreover, increased cytosolic localization stability ARE-containing genes. Mouse orthologous Parail downregulated macrophages mice atherosclerosis. attenuated proinflammatory Conclusions: Upregulation under acute conditions contributes proresolution mechanisms -ELAVL1 interactions. Conversely, downregulation diseases enhances impairs further augment inflammation. Thus, inflammation-resolving represent targets combat diseases.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (54)
CITATIONS (12)